To support the Client’s Provider-to-Provider virtual care services, Webdigiology is developing a HIPAA-compliant telehealth management platform based on Microsoft Cloud for Healthcare. The solution leverages Microsoft Azure, Microsoft Dynamics 365, and Microsoft Power Platform to streamline virtual consultations, care coordination, and partner relationship management.
The Client needed a centralized solution to cover generic and non-generic short-living chemotherapy drugs and TPN production (such as cyclophosphamide, 5-FU, cisplatin and more), stock control, client information and financial transactions (direct sales). This solution was to be used not only at the organization, but also at its medical customers’ facilities.
Eager to help AKLOS Health realize its groundbreaking idea, Webdigiology assembled a project team comprising a project manager, a business analyst, a regulatory compliance consultant, a UX/UI designer, 2 Xamarin developers, 2 front-end developers, 4 back-end developers, and a QA engineer.
The Client decided to replace its 20-year-old underwriting solution for aviation insurance. The solution was used by the Client’s underwriters, policy administrators, and external brokers located worldwide. At a certain point, the system became no longer viable for handling the increasingly complex underwriting workflows and couldn’t deliver a smooth user experience.
Webdigiology's team successfully released numerous important customized versions of one of the Client’s product for large pharmaceutical companies, such as GSK (GlaxoSmithKline) and AstraZeneca.
For another Client’s product, Webdigiology's team significantly improved the application functionality by introducing a new component that transforms visualized chemistry elements into text names of chemistry components.
The Client relied on the out-of-the box on-premises loan management software to centralize customer and financial data, automate lending and borrowing processes, and control loan repayment. The software didn’t provide a full scope of necessary functionality and couldn’t be efficiently customized to the Client’s specific loan management needs. Also, the prebuilt tool failed to smoothly integrate with the Client’s corporate software and essential external systems. So, the Client decided to invest in creating their own loan management system that would be fully tailored to their unique business requirements.
Back in the day, when our Client focused on a limited range of investment options, Microsoft Excel’s functionality was sufficient to plan investments and monitor their performance. As the Client’s service scope, custodian base, and investment volume scaled, conventional spreadsheets became no longer viable for managing the growing number of complex multi-asset portfolios.
What's more, the limitations of the existing AI assistants can often complicate real-time data exchange with hospital systems, such as scheduling systems, EHRs, and practice management software (PMS). Consequently, some AI appointment scheduling assistants may rely on manual entry or batch processes to update scheduling details and can't access physician availability in real time during the call.
Brush Claims, previously known as Brush Country Claims, has been in the insurance business since 1991, offering third-party P&C adjustment services for daily and catastrophic claims. Striving to deliver first-class experiences for its B2B customers and help carriers settle claims more efficiently, the company developed Hubvia, a proprietary suite of web-based tools enabling end-to-end claim processing automation.
The Client is a US-based NGO dedicated to conducting research in behavioral sciences, educating the public about mental disorders, and delivering evidence-based mental health care. Since its foundation, the organization has been engaged in clinical research on neuroscience and has published over 2,000 papers. The Client’s team of psychologists, psychiatrists, social workers, and speech therapists provides mental health care services both in person and through video calls, serving over 15,000 patients.
